Pharmacokinetics and Safety of Ticarcillin-clavulanate in Infants
NCT01229046 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2012-11-14
Summary
This study will evaluate the safety, tolerability and PK of ticarcillin-clavulanate in infants \<91 days of age with suspected systemic infection.
Conditions
Interventions
- DRUG
-
Ticarcillin-clavulanic acid
5 doses of IV ticarcillin-clavulanate infants \< 14 days PNA will receive 75 mg/kg Q12 infants ≥ 14 days PNA will receive 75 mg/kg Q8
Sponsors & Collaborators
-
Phillip Brian Smith
lead OTHER
Study Design
- Allocation
- NA
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Max Age
- 90 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-30
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)
NCT01669980 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Randomized Controlled Trial for Antibiotic Exposure in Neonatal Sepsis Using Neutrophil CD64
NCT01825421 ·Status: WITHDRAWN ·Phase: NA
-
Pharmacokinetics (PK) of Antistaphylococcal Antibiotics in Infants (NICHD-2012-02-Staph Trio)
NCT01728363 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety of Piperacillin-tazobactam in Neonates
NCT00873327 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis
NCT00646399 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile
NCT01744730 ·Status: COMPLETED ·Phase: PHASE1
-
Use of a Loading Dose of Vancomycin in Pediatric Dosing
NCT01290237 ·Status: TERMINATED ·Phase: NA
-
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
NCT01019395 ·Status: COMPLETED ·Phase: PHASE1
-
Surgical Site Infection Study
NCT01449669 ·Status: COMPLETED
-
Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
NCT00136292 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection
NCT02688790 ·Status: TERMINATED ·Phase: PHASE1
-
Neonatal Vancomycin Trial
NCT02790996 ·Status: TERMINATED ·Phase: PHASE2
-
Optimizing Vancomycin Therapy in Children
NCT05691309 ·Status: COMPLETED
-
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
NCT02266706 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Teicoplanin in Intensive Care and Haematology Patients
NCT04096092 ·Status: COMPLETED
-
Comparing Tigecycline Vs. Colistimethate in CNS Infections
NCT06702943 ·Status: NOT_YET_RECRUITING
-
A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)
NCT02750761 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)
NCT03230916 ·Status: COMPLETED ·Phase: PHASE1
-
Teicoplanin in Treating Septicemia in Patients Who Are Receiving Chemotherapy Through a Central Venous Catheter
NCT00024453 ·Status: UNKNOWN ·Phase: NA
-
A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
NCT01026636 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Effectiveness of Intravenous v. Oral Antibiotic Therapy for Serious Bacterial Infections
NCT02311452 ·Status: COMPLETED
-
Population Pharmacokinetics of Amikacin in Neonates
NCT04867135 ·Status: COMPLETED
-
Safety of 1 g and 2 g of Cefazolin in Pediatric Subjects
NCT03231228 ·Status: TERMINATED ·Phase: PHASE4
-
Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia
NCT00914888 ·Status: WITHDRAWN ·Phase: PHASE3
-
Antibiotic Prophylaxis in Rhinoplasty
NCT04194216 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3